View Item 

Show simple item record

Menstrual Issues in Adolescents with Physical and Developmental Disabilities

dc.contributor.authorQuint, Elisabeth H.en_US
dc.date.accessioned2010-06-01T19:03:10Z
dc.date.available2010-06-01T19:03:10Z
dc.date.issued2008-06en_US
dc.identifier.citationQuint , Elisabeth H. (2008). " Menstrual Issues in Adolescents with Physical and Developmental Disabilities ." Annals of the New York Academy of Sciences 1135(1 The Menstrual Cycle and Adolescent Health ): 230-236. <http://hdl.handle.net/2027.42/72241>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72241
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18574229&dopt=citationen_US
dc.format.extent103744 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2008 New York Academy of Sciencesen_US
dc.subject.otherMenstruationen_US
dc.subject.otherAdolescentsen_US
dc.subject.otherDevelopmental Disabilitiesen_US
dc.subject.otherPhysical Disabilitiesen_US
dc.subject.otherMenstrual Hygieneen_US
dc.titleMenstrual Issues in Adolescents with Physical and Developmental Disabilitiesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Obstetrics and Gynecology, Division of Gynecology, University of Michigan Health System, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid18574229en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72241/1/annals.1429.020.pdf
dc.identifier.doi10.1196/annals.1429.020en_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceKaplowitz, P. 2006. Pubertal development in girls: secular trends. Curr. Opinion Obstet. Gynecol. 18: 487 – 491.en_US
dc.identifier.citedreferenceMcDowell, M.A., D.J. Brody & J.P. Hughes. 2007. Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999–2004. J. Adolesc. Health 40: 227 – 231.en_US
dc.identifier.citedreferenceKnickmeyer, R.C., S. Wheelwright, R. Hoekstra & S. Baron-Cohen. 2006. Age of menarche in females with autism spectrum conditions. Devel. Med. Child Neurol. 48: 1007 – 1008.en_US
dc.identifier.citedreferenceWorley, G., C.M. Houlihan, M.E. Herman-Giddens, et al. 2002. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 110: 897 – 902.en_US
dc.identifier.citedreferenceCento, R.M., M. Ciampelli, C. Proto, et al. 2001. Neuroendocrine features of pubertal development in females with mental retardation. Gynecol. Endocrinol. 15: 178 – 183.en_US
dc.identifier.citedreferenceCento, R.M., L. Ragusa, C. Proto, et al. 1996. Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome. Gynecol. Endocrinol. 10: 133 – 137.en_US
dc.identifier.citedreferenceScola, P.S. & S.M. Pueschel. 1992. Menstrual cycles and basal body temperature curves in women with Down syndrome. Obstet. Gynecol. 79: 91 – 94.en_US
dc.identifier.citedreferenceBauer, J., J.L. Isojarvi, A.G. Herzog, et al. 2002. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and treatment. J. Neurol. Neurosurg. Psych. 73: 121 – 125.en_US
dc.identifier.citedreferenceBilo, L., R. Meo, C. Nappi, et al. 1988. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 29: 612 – 619.en_US
dc.identifier.citedreferenceHerzog, A.G. & S.C. Schachter. 2001. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 42: 311 – 315.en_US
dc.identifier.citedreferenceIsojarvi, J.I.T., T.J. Latikainen, A.J. Pakarinen, et al. 1993. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N. Engl. J. Med. 329: 1383 – 1388.en_US
dc.identifier.citedreferenceWieck, A. & P.M. Haddad. 2003. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: selective literature review. Br. J. Psych. 182: 199 – 204.en_US
dc.identifier.citedreferenceCohen, W.I. 2006. Current dilemmas in Down syndrome clinical care: celiac disease, thyroid disorders, and atlanto-axial instability. Am. J. Med. Genet. Semin. Med. Genet. 142: 141 – 148.en_US
dc.identifier.citedreferenceDizon, C.D., L.M. Allen & M.P. Ornstein. 2005. Menstrual and contraceptive issues among young women with developmental disability: a retrospective review of cases of the Hospital for Sick Children, Toronto. J. Ped. Adolescent. Gynecol. 18: 157 – 162.en_US
dc.identifier.citedreferenceCsermely, T., L. Halvax, M. Vizer et al. 2007. Relationship between adolescent amenorrhea and climacteric osteoporosis. Maturitas 56: 368 – 374.en_US
dc.identifier.citedreferenceMurphy, N.A. & E.R. Elias. 2006. Sexuality of children and adolescents with developmental disabilities. Pediatrics 118: 398 – 403.en_US
dc.identifier.citedreferenceQuint, E.H., T.E. Elkins, C.A. Sorg & S. Kope. 1999. The treatment of cyclical behavioral changes in women with mental disabilities. J. Ped. Adolesc. Gynecol. 12: 139 – 142.en_US
dc.identifier.citedreference18.  American College of Obstetrics and Gynecology. 2000. ACOG practice Bulletin: Premenstrual Syndrome. Washington, DC.en_US
dc.identifier.citedreferenceDavis, A.R. & C.L. Westhoff. 2001. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J. Ped. Adolesc. Gynecol. 14: 3 – 8.en_US
dc.identifier.citedreferenceBorges, L.E., R.P. Andrade, J.M. Aldrighi, et al. 2006. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception 74: 446 – 450.en_US
dc.identifier.citedreferenceWyatt, K.M., P.W. Dimmock & P.M O'Brien. 2005. Selective serotonin reuptake inhibitors for premenstrual syndrome. In The Cochrane Database of Systematic Reviews (3) Art. No: CD001396.en_US
dc.identifier.citedreferenceGray, S.H. & S.J. Emans. 2007. Abnormal vaginal bleeding in adolescents. Ped. Rev. 28: 175 – 182.en_US
dc.identifier.citedreferenceAlbanese, A. & N.W. Hopper. 2007. Suppression of menstruation in adolescents with severe learning disabilities. Arch. Dis. Child. 92: 629 – 32.en_US
dc.identifier.citedreferenceBonnar, J. & B.L. Sheppard. 1996. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 313: 579 – 582.en_US
dc.identifier.citedreferenceEdelman, A.B., M.F. Gallo, J.T. Jensen, et al. 2005. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. In Cochrane Database Syst. Rev. CD004695.en_US
dc.identifier.citedreferenceSucato, G.S. & K.L. Gerschultz. 2005. Extended cycle hormonal contraception in adolescents. Curr. Opin. Obstet. Gynecol. 17: 461 – 465.en_US
dc.identifier.citedreferenceRousseau, M.C. & B. Guillotel. 2001. Risk factors for deep venous thrombosis in tetraparesic mentally retarded patients. Brain Injury 15: 1041 – 1044.en_US
dc.identifier.citedreferenceLohiya, G.S., F.M. Crinella, L. Tan-Figueroa & S. Go. 2005. Deep vein thrombosis in a tetraparesic patient with mental retardation: case report and review of the literature. Brain Injury 19: 739 – 742.en_US
dc.identifier.citedreferenceSchreijer, A.J., S.C. Cannegieter, J.C. Meijers, et al. 2006. Activation of coagulation system during air travel: a crossover study. Lancet 367: 832 – 838.en_US
dc.identifier.citedreferenceTanis, B.C. & F.R. Rosendaal. 2003. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Semin. Vasc. Med. 3: 69 – 84.en_US
dc.identifier.citedreferenceSavelli, S.L., B.A. Kerlin, M.A. Springer, et al. 2006. Recommendations for screening for thrombophilic tendencies in teenage females prior to contraceptive initiation. J. Ped. Adolesc. Gynecol. 19: 313 – 316.en_US
dc.identifier.citedreferenceCole, J.A., H. Norman, M. Doherty, et al. 2007. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet. Gynecol. 109: 339 – 346.en_US
dc.identifier.citedreferenceDiVasta, A.D. & C.M. Gordon. 2006. Bone health in adolescents. Adolesc. Med. Clin. 17: 639 – 652.en_US
dc.identifier.citedreference34.  Understanding the needs of women with epilepsy or risk OC failure. 1998. In Contraceptive Technol. Update 19: 109 – 1011.en_US
dc.identifier.citedreferenceArias, R.D., J.K. Jain, C. Brucker, et al. 2006. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception 74: 234 – 238.en_US
dc.identifier.citedreferenceWesthoff, C., J.K. Jain, I. Milsom, et al. 2007. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception 75: 261 – 267.en_US
dc.identifier.citedreferenceBonny, A., K. Camlin, R. Harvey, et al. 2003. Prospective analysis of weight changes in adolescent females initiating depot medroxyprogesterone acetate (DMPA), oral contraceptive pills, or no hormonal method. J. Adolesc. Health 32: 134.en_US
dc.identifier.citedreferenceCromer, B.A., M. Stager, A. Bonny et al. 2004. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J. Adolesc. Health 35: 434 – 441.en_US
dc.identifier.citedreferenceLopez, L.M., D.A. Grimes, K.F. Schulz, et al. 2006. Steroidal contraceptives: effect on bone fractures in women. In Cochrane Database of Systematic Reviews. (4):CD006033.en_US
dc.identifier.citedreferenceKing, W., R. Levin, R. Schmidt, et al. 2003. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev. Med. Child. Neurol. 45: 12 – 16.en_US
dc.identifier.citedreferenceHenderson, R.C., R.K. Lark, M.J. Gurka, et al. 2002. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110: 1 – 10.en_US
dc.identifier.citedreferenceWatson, K.C., M.J. Lentz & K.C. Cain. 2006. Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities. Womens' Health Issues 16: 346 – 352.en_US
dc.identifier.citedreferenceSchrager, S., C. Kloss & A.W. Ju. 2007. Prevalence of fractures in women with intellectual disabilities: a chart review. J. Intellect. Disabil. Res. 51: 253 – 259.en_US
dc.identifier.citedreferencePluskiewicz, W., B. Drozdzowska, A. Lyssek-Boro, et al. 2006. Densitometric and quantitative ultrasound measurements and laboratory investigations in wheelchair-bound patients. J. Clin. Densitom. 9: 78 – 83.en_US
dc.identifier.citedreferenceFunk, S., M.M. Miller, D.R. Mishell, Jr., et al. 2005. The Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 71: 319 – 326.en_US
dc.identifier.citedreferenceHidalgo, M., L. Bahamondes, M. Perrotti, et al. 2002. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 65: 129 – 132.en_US
dc.identifier.citedreferenceSuhonen, S., M. Haukkamaa, T. Jakobsson & I. Rauramo. 2004. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 69: 407 – 412.en_US
dc.identifier.citedreferenceParansky, O.I. & R.K. Zurawin. 2003. Management of menstrual problems and contraception in adolescents with mental retardation: a medical, legal, and ethical review with new suggested guidelines. J. Pediat. Adolesc. Gynecol. 16: 223 – 235.en_US
dc.identifier.citedreference49.  American College of Obstetrics and Gynecology. 1999. Sterilization of women, including those with mental disabilities. In ACOG Committee Opinion 216. Washington, DC.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
annals.1429.020.pdf
Size:
101.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.